High prevalence of virulence-associated genotypes in Helicobacter pylori clinical isolates in the Region del Maule, Chile

Scandinavian Journal of Infectious Diseases

Volumn 43, Issue 8, 2011, Pages 652-655

  González, Ileana ^a   Romero, Jacqueline ^a   Rodríuez, Boris ^b   Llanos, Jorge ^c   Morales, Erik ^c   Figueroa, Héctor ^a   Perez Castro, Ramón ^a   Valdés, Eliana ^c   Cofre, Cecilia ^c   Rojas, Armando ^a  

^a UNIVERSIDAD CATÓLICA DEL MAULE   (Chile)

^b NATL CENTER FOR SCIENTIFIC RESEARCH   (Cuba)

^c HOSPITAL REGIONAL DE TALCA   (Chile)

Author keywords

babA2; cagA; Chile; EPIYA; Helicobacter pylori; vacA

Indexed keywords

BABA ADHESIN; BACTERIAL PROTEIN; CAGA PROTEIN; UNCLASSIFIED DRUG; VACUOLATING TOXIN;

ARTICLE; BACTERIAL GENE; BACTERIAL GENOME; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CANCER MORTALITY; CHILE; CHRONIC GASTRITIS; DYSPEPSIA; EPIYA MOTIF; GENETIC POLYMORPHISM; GENOTYPE; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; NEUTROPHIL CHEMOTAXIS; POLYMERASE CHAIN REACTION; PREVALENCE; PROTEIN STRUCTURE; STOMACH BIOPSY; STOMACH CANCER;

ADHESINS, BACTERIAL; AMINO ACID MOTIFS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CHI-SQUARE DISTRIBUTION; CHILE; GASTRIC MUCOSA; GENOTYPE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PREVALENCE; VIRULENCE;

EID: 79960443215     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365548.2011.572909     Document Type: Article

References (30)

1. Costa AC, Figueiredo C, Touati E. Pathogenesis of Helicobacter pylori infection. Helicobacter 2009;4:5-20
2. Ferreccio C, Rollán A, Harris PR, Serrano C, Gederlini A, Margozzini P, et al. Gastric cancer is related to early Helicobacter pylori infection in a high-prevalence country. Cancer Epidemiol Biomarkers Prev 2007;6:662-7 (Pubitemid 46650566)
3. World Health Organization- International Agency for Research on Cancer (IARC). CANCER Mondial . Globocan 2008. Lyon, France: WHO; 2008. Available at: http://wwwdep. iarc.fr/ (accessed 19 January 2010)
4. Departamento de Estadísticas. Bases de datos de mortalidad por tumores malignos, 1990-2008. Santiago, Chile: Ministerio de Salud, República de Chile; 2009
5. Atherton JC. The pathogenesis of Helicobacter pyloriinduced gastro-duodenal diseases. Annu Rev Pathol 2006;1:1095-96
6. Backert S, Selbach M. Role of type IV secretion in Helicobacter pylori pathogenesis Cell Microbiol 2008;10:1573-81 (Pubitemid 352006141)
7. Backert S, Tegtmeyer N, Selbach, M. The versatility of Helicobacter pylori CagA effector protein functions: the master key hypothesis. Helicobacter 2010;15:163-76
8. Argent RH, Kidd M, Owen RJ, Thomas RJ, Limb MC, Atherton JC. Determinants and consequences of different levels of CagA phosphorylation for clinical isolates of Helicobacter pylori. Gastroenterology 2004;127:514-23 (Pubitemid 39091900)
9. Atherton JC, Cao P, Peek RM, Tummuru MK Jr, Blaser MJ, Cover TL. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specifi c vacA types with cytotoxin production and peptic ulceration. J Biol Chem 1995;270:17771-7
10. Ilver D, Arnqvist A, Ogren J, Frick JIM, Kersulyte D, Incecik ET, et al. Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science 1998;279:373-7 (Pubitemid 28063371)
11. Gerhard M, Lehn N, Neumayer N, Boren T, Rad R, Schepp W, et al. Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin. Proc Natl Acad Sci U S A 1999;96:12778-83 (Pubitemid 29513579)
12. Wilson K. Preparation of genomic DNA from bacteria. In: Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K, editors. Current protocols in molecular biology. New York: John Wiley & Sons; 1987 pp 2.41-2.45
13. Li C, Musich PR, Ha T, Ferguson DA, Patel NR, Chi DS, Thomas E. High prevalence of Helicobacter pylori in saliva demonstrated by a novel PCR assay. J Clin Pathol 1995;48:662-6
14. Sheu BS, Sheu SM, Yang HB, Huang AH, Wu JJ. Host gastric Lewis expression determines the bacterial density of Helicobacter pylori in babA2 genopositive infection. Gut 2003;52:927-32
15. Tummuru MK, Cover TL, Blaser MJ. Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production. Infect Immun 1993;61:1799-809 (Pubitemid 23145878)
16. Argent RH, Zhang Y, Atherton JC. Simple method for determination of the number of Helicobacter pylori CagA variable- region EPIYA tyrosine phosphorylation motifs by PCR. J Clin Microbiol 2005;43:791-5 (Pubitemid 40256036)
17. Dixon MF, Genta RM, Yardley JH, Correa P. Classifi cation and grading of gastritis. The updated Sydney System. Am J Surg Pathol 1996;20:1161-81 (Pubitemid 26336840)
18. Quiroga AJ, Cittelly DM, Bravo MM. B abA2 , o ipA and c agE Helicobacter pylori genotypes in Colombian patients with gastroduodenal diseases. Biomedica 2005;25:325-34
19. Con SA, Takeuchi H, Valerín AL, Con-Wong R, Con-Chin GR, Con-Chin VG, et al. Diversity of Helicobacter pylori cagA and vacA genes in Costa Rica: its relationship with atrophic gastritis and gastric cancer. Helicobacter 2007;12: 547-52 (Pubitemid 47312393)
20. Debets-Ossenkopp YJ, Reyes G, Mulder J, aan de Stegge BM, Peters JT, Savelkoul PH, et al. Characteristics of clinical Helicobacter pylori strains from Ecuador. J Antimicrob Chemother 2003;51:141-5 (Pubitemid 36163839)
21. Garcia GT, Aranda KR, Gonç alves ME, Cardoso SR, Iriya K, Silva NP, Scaletsky IC. High prevalence of clarithromycin resistance and cagA , vacA , iceA2 , and babA2 genotypes of Helicobacter pylori in Brazilian children. J Clin Microbiol 2010;48:4266-8
22. Chiarini A, Cal C, Bonura C, Gullo A, Giuliana G, Peralta S, et al. Prevalence of virulence-associated genotypes of Helicobacter pylori and correlation with severity of gastric pathology in patients from western Sicily, Italy. Eur J Clin Microbiol Infect Dis 2009;28:437-46
23. Yamaoka Y. Roles of Helicobacter pylori BabA in gastroduodenal pathogenesis. World J Gastroenterol 2008;14:4265-72
24. Yamaoka Y. Mechanisms of disease: H. pylori virulence factors. Nat Rev Gastroenterol Hepatol 2010;7:629-34
25. Sugimoto M, Yamaoka Y. The association of vacA genotype and Helicobacter pylori-related disease in Latin American and African populations. Clin Microbiol Infect 2009;15:835-42
26. Con SA, Takeuchi H, Nishioka M, Morimoto N, Sugiura T, Yasuda N, Con-Wong R. Clinical relevance of Helicobacter pylori babA2 and babA2/B in Costa Rica and Japan. World J Gastroenterol 2010;16:474-8
27. Lai CH, Kuo YC, Chen FY, Chao SK, Poon SK, Chang CS, Wang WC. High prevalence of cagA - and babA2 -positive Helicobacter pylori clinical isolates in Taiwan. J Clin Microbiol 2002;40:3860-2
28. García A, Barra R, Delgado C, Kawaguchi F, Trabal N, Montenegro S, Gonzá lez C. Genotypying of clinical isolates of Helicobacter pylori by cagA , vacA and babA2 virulence associated genes. First detection of a babA2 positive strain in Chilean patients. Rev Med Chile 2006;134:981-8 (Pubitemid 44800189)
29. Pride DT, Meinersmann RJ, Blaser MJ. Allelic variation within Helicobacter pylori babA and babB . Infect Immun 2001;69:160-71
30. Basso D, Zambon CF, Letley DP, Stranges A, Marchet A, Rhead JL, et al. Clinical relevance of Helicobacter pylori cagA and vacA gene polymorphisms. Gastroenterology 2008; 135:91-9 (Pubitemid 351899019)